DEA head refuses to comment on marijuana rescheduling

Published on 7 May 2024 on Seeking Alpha

At a congressional hearing on Tuesday, the head of the U.S. Drug Enforcement Administration (DEA),...

Read the rest of the article

Start tracking your investments with Statfolio

Amplify ETFs has consolidated its global and US funds that offer exposure to the cannabis industr...

etf.com · via Yahoo Finance 30 Jan 2025

The cannabis sector is showing signs of stabilization following a harsh post-election sell-off tr...

Benzinga 7 Nov 2024

Following Donald Trump's presidential election victory Tuesday, the cannabis sector took a sharp ...

Benzinga 6 Nov 2024

Cannabis reform faced a challenging moment in the 2024 U.S. elections, with several key state ini...

Benzinga 6 Nov 2024

Tilray (TSX:TLRY) Brands' shares declined more than 11%, while the U.S.-listed shares of SNDL and...

Investing.com 6 Nov 2024

Deadlock: the Harris vs Trump trade

Investing.com 5 Nov 2024

Wall Street has experienced a robust upswing in May, driven by fresh expectations of Federal Rese...

Zacks via Yahoo Finance 31 May 2024

Cannabis stocks have been hot buys of late as investors recently learned that the Biden...

Motley Fool · via Yahoo Finance 22 May 2024

At a congressional hearing on Tuesday, the head of the U.S. Drug Enforcement Administration (DEA)...

Seeking Alpha 7 May 2024

Justice Department said it plans to reclassify marijuana as a less dangerous drug. Big gainers...

Investing.com 7 May 2024